Serum Institute Covovax price cut to Rs 225 per dose

The price of the vaccine, Covovax, is learnt to have been revised on the CoWIN portal.

Published On 2022-05-04 07:56 GMT   |   Update On 2022-05-05 14:42 GMT

New Delhi: A day after its Covid shot Covovax was included on the CoWIN portal for inoculation of children aged 12-17 years at private vaccination centres, the Serum Institute of India (SII) on Tuesday reduced the price of each dose of the vaccine from Rs 900 to Rs 225, excluding taxes. 

Following recommendation of the National Technical Advisory Group on Immunisation (NTAGI) the provision of the vaccine option was included on the portal on Monday. 
On Tuesday, Director for Government and Regulatory Affairs, SII, Prakash Kumar Singh, is learnt to have communicated to the government that the firm is reducing the price of each dose from Rs 900 to Rs 225 plus goods and services tax (GST) for private hospitals. In addition, a private hospital can charge up to Rs 150 as service charge. 
Advertisement
The price of the vaccine, Covovax, is learnt to have been revised on the CoWIN portal. 

COVOVAX is indicated for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older. 

Read also: CDSCO panel seeks additional data on Serum Institute EUA application for Covovax use in 7-11 year-olds 

India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12-17 age group, subject to certain conditions, on March 9. 
Currently, children aged 12 to 14 years are vaccinated with Biological E's Corbevax, while those in the 15-18 age group are being administered Bharat Biotech's Covaxin free of cost at government vaccination centres. 
At private centres a dose of Covaxin costs Rs 386, including GST, while Corbevax costs Rs 990. 

Read also: Serum institute Covovax first Indian COVID vaccine to be sold in Europe: Adar Poonawalla

Tags:    
Article Source : With inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News